Abstract
A family of cytokine-inducible SH2 proteins (CISs) has recently been identified and the number of family members is growing. In this family, the central SH2 domain and C-terminal (about 40 amino acids) (CIS homology domain; CH domain) are well conserved, while N-terminal region shares little similarity and varies in length. Most of them appear to be induced after stimulation with several different cytokines and at least three of them (CIS1, CIS3 and JAB) negatively regulate cytokine signal transduction by various means. Forced expression of CIS1 inhibits STAT5 activation by binding to cytokine receptors, whereas CIS3 and JAB directly binds to the kinase domain of JAKs, thereby inhibiting tyrosine kinase activity. Therefore, these CIS family members seem to function in a classical negative feedback loop of cytokine signaling. They may also be involved in suppression between cytokines frequently found in immune and inflammatory responses. JAB is found to inhibit interferon signaling, suggesting that elevated expression of JAB is involved in interferon-resistance. The mechanisms by which these inhibitors of cytokine signal transduction exert their effects and their physiological functions are crucial issues which need to be and will be addressed in the near future.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Yoshimura, A. The CIS/JAB family: novel negative regulators of JAK signaling pathways. Leukemia 12, 1851–1857 (1998). https://doi.org/10.1038/sj.leu.2401238
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.leu.2401238
Keywords
This article is cited by
-
JAKs, STATs and Src kinases in hematopoiesis
Oncogene (2002)
-
Effects of inducible MEK1 activation on the cytokine dependency of lymphoid cells
Leukemia (2001)
-
A conditionally-active form of MEK1 results in autocrine transformation of human and mouse hematopoietic cells
Oncogene (2000)
-
IL-3 signaling and the role of Src kinases, JAKs and STATs: a covert liaison unveiled
Oncogene (2000)
-
Janus kinases: components of multiple signaling pathways
Oncogene (2000)